Ophthalmology · Flushing, NY
NPI
1255607206
Since 2012
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
13636 39th Ave Ste 2
Flushing, NY, 11354
Phone (646) 530-8400
Groups this clinician bills Medicare through
Medicare paid, 2024
$112K
2,299 services
Medicare patients, 2024
78
Average age 74
Drug cost, 2024
$1.1M
4,088 prescriptions
Company payments, 2025
$1,292
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yufei Tu was code 95004 (test - miscellaneous), 1,552 times for 25 patients. In total Yufei Tu billed 2,299 services in 31 codes, and Medicare paid $112K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,552 | 25 | $3.47 | $5,378 |
| 68761 Eye | Office | 157 | 61 | $91.81 | $14K |
| 92083 Vision, Hearing, and Speech Services | Office | 100 | 65 | $56.94 | $5,694 |
| 92250 Angiography | Office | 61 | 50 | $30.25 | $1,845 |
| 92133 Computerized Ophthalmic Imaging | Office | 60 | 53 | $30.20 | $1,812 |
| 99213 Office E&M - Established | Office | 54 | 33 | $70.05 | $3,783 |
| 92020 Ophthalmological E&M | Office | 46 | 46 | $24.30 | $1,118 |
| 99204 Office E&M - New | Office | 43 | 43 | $122.28 | $5,258 |
| 99214 Office E&M - Established | Office | 39 | 26 | $110.01 | $4,291 |
| 65778 Eye | Office | 39 | 22 | $1,005.19 | $39K |
| 76514 Ultrasound - Nonspecific | Office | 30 | 30 | $9.56 | $287 |
| 92025 Test - Miscellaneous | Office | 17 | 14 | $30.37 | $516 |
| 92136 Ultrasound - Nonspecific | Office | 15 | 15 | $40.37 | $606 |
By year: 2022 $39K for 357 services; 2023 $68K for 526 services; 2024 $112K for 2,299 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yufei Tu prescribed most often to Medicare patients was Restasis (Cyclosporine), with 875 prescriptions and refills. In total Yufei Tu wrote 4,088 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 875 | 930 | 277 | $575K |
| Prednisolone Acetate Generic | 488 | 715 | 242 | $33K |
| Ofloxacin Generic | 338 | 385 | 172 | $5,625 |
| Latanoprost Generic | 273 | 341 | 69 | $1,690 |
| Cyclosporine Generic | 270 | 323 | 132 | $86K |
| Ketorolac Tromethamine Generic | 267 | 373 | 142 | $9,095 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 238 | 461 | 67 | $3,235 |
| Tyrvaya Varenicline Tartrate | 176 | 181 | 51 | $113K |
| Azelastine Hcl Generic | 145 | 154 | 77 | $2,370 |
| Brimonidine Tartrate Generic | 144 | 259 | 42 | $4,301 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 103 | 123 | 22 | $39K |
| Rhopressa Netarsudil Mesylate | 84 | 114 | 21 | $28K |
| Xiidra Lifitegrast | 74 | 79 | 18 | $54K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 71 | 76 | 51 | $859 |
| Acetazolamide Er Acetazolamide | 69 | 77 | 22 | $4,396 |
Brand drugs: 2,367 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yufei Tu $1,292 ($1,292 in general payments such as food, travel and fees) from 10 companies. The largest payer was Alcon Vision LLC with $462.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 13 | $462 |
| Bausch & Lomb Americas Inc. BLCO | 11 | $277 |
| Oyster Point Pharma, Inc. | 11 | $218 |
| Harrow Eye, LLC | 5 | $130 |
| Tarsus Pharmaceuticals, Inc. TARS | 4 | $70.44 |
| Amgen Inc. AMGN | 2 | $37.32 |
| Abbvie Inc. ABBV | 1 | $29.14 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $25.5 |
| Dompe US, Inc. | 1 | $22.5 |
| New World Medical,Inc. | 1 | $20.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.